Axonis Therapeutics Employee Directory
Biotechnology ResearchMassachusetts, United States11-50 Employees
Axonis Therapeutics is a Boston-based biotechnology company focused on developing medicines that enhance inhibitory neurotransmission in the brain by modulating KCC2, a key chloride transporter involved in CNS signaling. Its work centers on translating discoveries from institutions such as Boston Children’s Hospital, Harvard, and Laval University into first- and best-in-class therapies, with AXN-027 as its lead candidate designed to potentiate KCC2 function for epilepsy and pain. Operating within the biotechnology research sector, the company positions itself in the neurotherapeutics space by pursuing a discovery engine aimed at addressing a significant mechanism in neural inhibition. The organization is positioned to pursue clinical development and research collaborations as it advances its neuroscience program from its Boston location. A recent development includes notable activity around a Series A financing and leadership appointments aligned with its growth, reflecting ongoing progress in its strategic execution and capability expansion.
1-888-653-2347 
support@leadiq.com 
